Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonel Trebicka

Showing results (471-480 of 512) with videos related to

Pageof 52
Sort By:
Gut|March 9, 2022
A faecal microbiota signature with high specificity for pancreatic cancerEce Kartal, Thomas S B Schmidt, Esther Molina-Montes, et al.
JHEP Reports : Innovation in Hepatology|January 29, 2024
Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosisJudit Vidal-González, Javier Martínez, Akhilesh Mulay, et al.
Hepatology Communications|December 27, 2021
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With CirrhosisHamish Innes, Hans Dieter Nischalke, Indra Neil Guha, et al.
Annals of Hepatology|October 13, 2025
Pruritus in primary biliary cholangitis: insights from the German PBC registry across secondary and tertiary careToni Herta, Annegret Franke, Tobias Müller, et al.
Gastroenterology|June 11, 2025
Defining Organ Failures in Patients with Cirrhosis: Consensus StatementsJasmohan S Bajaj, Debbie L Shawcross, Ashok Choudhury, et al.
Gastroenterology|March 26, 2019
Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated CirrhosisJavier Fernández, Joan Clària, Alex Amorós, et al.
Zeitschrift Fur Gastroenterologie|September 3, 2024
Sub-optimal therapy of patients with primary biliary cholangitis (PBC) in the real-life stetting of the German PBC cohortJohannes Wiegand, Annegret Franke, Tobias Müller, et al.
Nature Communications|July 2, 2025
The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trialJohanne K Hansen, Mads Israelsen, Suguru Nishijima, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2025
The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic nicheLaura Wormser, Valerie Fritz, Melanie Kappelmann-Fenzl, et al.
Zeitschrift Fur Gastroenterologie|December 9, 2025
Clinical characteristics of newly diagnosed patients with primary biliary cholangitis (PBC) indicate the need for better awareness on timely diagnosis and adequate UDCA therapyKerstin Stein, Wolf P Hofmann, Annegret Franke, et al.
Pageof 52

Showing results (471-480 of 512) with videos related to

Sort By:
Pageof 52
Gut|March 9, 2022
A faecal microbiota signature with high specificity for pancreatic cancerEce Kartal, Thomas S B Schmidt, Esther Molina-Montes, et al.
JHEP Reports : Innovation in Hepatology|January 29, 2024
Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosisJudit Vidal-González, Javier Martínez, Akhilesh Mulay, et al.
Hepatology Communications|December 27, 2021
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With CirrhosisHamish Innes, Hans Dieter Nischalke, Indra Neil Guha, et al.
Annals of Hepatology|October 13, 2025
Pruritus in primary biliary cholangitis: insights from the German PBC registry across secondary and tertiary careToni Herta, Annegret Franke, Tobias Müller, et al.
Gastroenterology|June 11, 2025
Defining Organ Failures in Patients with Cirrhosis: Consensus StatementsJasmohan S Bajaj, Debbie L Shawcross, Ashok Choudhury, et al.
Gastroenterology|March 26, 2019
Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated CirrhosisJavier Fernández, Joan Clària, Alex Amorós, et al.
Zeitschrift Fur Gastroenterologie|September 3, 2024
Sub-optimal therapy of patients with primary biliary cholangitis (PBC) in the real-life stetting of the German PBC cohortJohannes Wiegand, Annegret Franke, Tobias Müller, et al.
Nature Communications|July 2, 2025
The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trialJohanne K Hansen, Mads Israelsen, Suguru Nishijima, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2025
The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic nicheLaura Wormser, Valerie Fritz, Melanie Kappelmann-Fenzl, et al.
Zeitschrift Fur Gastroenterologie|December 9, 2025
Clinical characteristics of newly diagnosed patients with primary biliary cholangitis (PBC) indicate the need for better awareness on timely diagnosis and adequate UDCA therapyKerstin Stein, Wolf P Hofmann, Annegret Franke, et al.
Pageof 52